Ellen Christina Caniglia, D.Sc.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Premature Birth | 9 | 2023 | 1781 | 1.960 |
Why?
|
AIDS Dementia Complex | 3 | 2018 | 153 | 1.450 |
Why?
|
HIV Infections | 22 | 2024 | 17328 | 1.160 |
Why?
|
Pregnancy Outcome | 9 | 2024 | 2915 | 1.010 |
Why?
|
Stillbirth | 6 | 2024 | 368 | 0.990 |
Why?
|
Substance-Related Disorders | 6 | 2024 | 4416 | 0.930 |
Why?
|
Botswana | 9 | 2024 | 1041 | 0.880 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2018 | 1896 | 0.850 |
Why?
|
Drug Monitoring | 2 | 2019 | 961 | 0.780 |
Why?
|
Anti-HIV Agents | 5 | 2019 | 4518 | 0.740 |
Why?
|
Quarantine | 1 | 2020 | 181 | 0.620 |
Why?
|
CD4 Lymphocyte Count | 4 | 2019 | 2569 | 0.620 |
Why?
|
HIV Protease Inhibitors | 3 | 2018 | 432 | 0.600 |
Why?
|
Epidemiologic Studies | 1 | 2021 | 672 | 0.600 |
Why?
|
Toxoplasmosis | 1 | 2018 | 93 | 0.580 |
Why?
|
Meningitis, Cryptococcal | 1 | 2018 | 67 | 0.580 |
Why?
|
Central Nervous System | 2 | 2015 | 1337 | 0.570 |
Why?
|
Viral Load | 6 | 2023 | 3329 | 0.570 |
Why?
|
Methamphetamine | 3 | 2023 | 165 | 0.560 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2018 | 133 | 0.550 |
Why?
|
Causality | 2 | 2021 | 1242 | 0.550 |
Why?
|
AIDS-Related Complex | 1 | 2016 | 107 | 0.540 |
Why?
|
Benchmarking | 1 | 2022 | 1044 | 0.520 |
Why?
|
Veterans | 3 | 2024 | 2641 | 0.480 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2018 | 662 | 0.460 |
Why?
|
Pregnancy Complications | 3 | 2022 | 2945 | 0.460 |
Why?
|
Anti-Retroviral Agents | 4 | 2023 | 1781 | 0.450 |
Why?
|
Travel | 1 | 2019 | 795 | 0.440 |
Why?
|
Pain | 4 | 2024 | 5074 | 0.420 |
Why?
|
Nervous System | 1 | 2016 | 543 | 0.420 |
Why?
|
Smoking Cessation | 1 | 2024 | 2053 | 0.410 |
Why?
|
Pregnancy | 15 | 2024 | 29822 | 0.390 |
Why?
|
Sexually Transmitted Diseases | 3 | 2023 | 662 | 0.390 |
Why?
|
Drug Users | 2 | 2023 | 134 | 0.390 |
Why?
|
RNA, Viral | 2 | 2019 | 2846 | 0.380 |
Why?
|
Fetal Development | 1 | 2016 | 769 | 0.360 |
Why?
|
Alcoholism | 1 | 2020 | 1972 | 0.340 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2024 | 2151 | 0.340 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2018 | 2199 | 0.320 |
Why?
|
Substance Abuse, Intravenous | 2 | 2023 | 530 | 0.310 |
Why?
|
Research Design | 2 | 2021 | 6165 | 0.300 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3240 | 0.300 |
Why?
|
Europe | 4 | 2018 | 3417 | 0.280 |
Why?
|
Infant, Newborn | 9 | 2024 | 26282 | 0.270 |
Why?
|
Dementia | 1 | 2020 | 2678 | 0.260 |
Why?
|
Benzoxazines | 2 | 2018 | 316 | 0.250 |
Why?
|
Maternal Mortality | 2 | 2024 | 301 | 0.240 |
Why?
|
Female | 33 | 2024 | 391766 | 0.230 |
Why?
|
HIV Seropositivity | 2 | 2023 | 960 | 0.230 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7423 | 0.230 |
Why?
|
Developed Countries | 2 | 2017 | 444 | 0.220 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2016 | 2502 | 0.220 |
Why?
|
Humans | 48 | 2024 | 760239 | 0.220 |
Why?
|
Crack Cocaine | 1 | 2023 | 32 | 0.220 |
Why?
|
Health Services Accessibility | 2 | 2021 | 5420 | 0.210 |
Why?
|
Models, Structural | 1 | 2021 | 341 | 0.190 |
Why?
|
Pharmacoepidemiology | 1 | 2024 | 350 | 0.190 |
Why?
|
Portraits as Topic | 1 | 2020 | 32 | 0.180 |
Why?
|
Mental Disorders | 1 | 2020 | 6828 | 0.180 |
Why?
|
Adult | 19 | 2024 | 220718 | 0.170 |
Why?
|
Pelvic Inflammatory Disease | 1 | 2020 | 96 | 0.170 |
Why?
|
Pouchitis | 1 | 2020 | 64 | 0.170 |
Why?
|
Alkynes | 2 | 2018 | 319 | 0.170 |
Why?
|
United States Department of Veterans Affairs | 1 | 2024 | 923 | 0.170 |
Why?
|
Computer Graphics | 1 | 2021 | 340 | 0.160 |
Why?
|
Anxiety | 3 | 2024 | 4558 | 0.160 |
Why?
|
Cyclopropanes | 2 | 2018 | 432 | 0.160 |
Why?
|
Micronutrients | 1 | 2022 | 381 | 0.160 |
Why?
|
International Classification of Diseases | 1 | 2024 | 892 | 0.160 |
Why?
|
Prospective Studies | 7 | 2020 | 54304 | 0.160 |
Why?
|
Cohort Studies | 8 | 2022 | 41340 | 0.160 |
Why?
|
Male | 22 | 2024 | 359943 | 0.150 |
Why?
|
Americas | 1 | 2018 | 111 | 0.150 |
Why?
|
Infant, Small for Gestational Age | 1 | 2020 | 461 | 0.150 |
Why?
|
Epidemiologic Research Design | 1 | 2021 | 368 | 0.150 |
Why?
|
Selection Bias | 1 | 2019 | 359 | 0.150 |
Why?
|
Reverse Transcriptase Inhibitors | 2 | 2018 | 620 | 0.140 |
Why?
|
Cocaine | 1 | 2022 | 958 | 0.140 |
Why?
|
Intention to Treat Analysis | 1 | 2018 | 414 | 0.140 |
Why?
|
Young Adult | 8 | 2024 | 59054 | 0.140 |
Why?
|
Depression | 4 | 2024 | 8101 | 0.130 |
Why?
|
Papillomavirus Vaccines | 1 | 2022 | 496 | 0.130 |
Why?
|
Folic Acid | 1 | 2022 | 1313 | 0.120 |
Why?
|
Cannabis | 1 | 2021 | 437 | 0.120 |
Why?
|
HIV-1 | 3 | 2017 | 6859 | 0.120 |
Why?
|
Communicable Disease Control | 1 | 2020 | 848 | 0.110 |
Why?
|
Middle Aged | 12 | 2024 | 220307 | 0.110 |
Why?
|
Iron | 1 | 2022 | 1787 | 0.110 |
Why?
|
Adrenal Cortex Hormones | 1 | 2022 | 1875 | 0.110 |
Why?
|
Logistic Models | 2 | 2020 | 13230 | 0.110 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14564 | 0.100 |
Why?
|
Vietnam | 2 | 2023 | 409 | 0.100 |
Why?
|
Case Management | 1 | 2014 | 272 | 0.100 |
Why?
|
United States | 7 | 2024 | 72181 | 0.100 |
Why?
|
Sexual Behavior | 4 | 2023 | 2177 | 0.100 |
Why?
|
Health Services Research | 1 | 2019 | 1811 | 0.100 |
Why?
|
Colitis | 1 | 2020 | 1230 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1925 | 0.100 |
Why?
|
Data Interpretation, Statistical | 1 | 2021 | 2690 | 0.090 |
Why?
|
Sepsis | 1 | 2024 | 2583 | 0.090 |
Why?
|
Attitude of Health Personnel | 2 | 2021 | 3880 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2022 | 1610 | 0.090 |
Why?
|
Dietary Supplements | 1 | 2022 | 3396 | 0.080 |
Why?
|
Survival Analysis | 2 | 2019 | 10074 | 0.080 |
Why?
|
Population Surveillance | 1 | 2019 | 2597 | 0.080 |
Why?
|
Opioid-Related Disorders | 1 | 2022 | 2152 | 0.070 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39067 | 0.070 |
Why?
|
Risk-Taking | 2 | 2023 | 1036 | 0.070 |
Why?
|
Mass Screening | 2 | 2020 | 5423 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2024 | 4788 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2020 | 4024 | 0.070 |
Why?
|
Risk Assessment | 2 | 2018 | 23942 | 0.070 |
Why?
|
Infant | 4 | 2024 | 36179 | 0.060 |
Why?
|
Mental Health | 1 | 2020 | 3239 | 0.060 |
Why?
|
Decision Making | 1 | 2019 | 3923 | 0.060 |
Why?
|
Research Personnel | 2 | 2021 | 587 | 0.060 |
Why?
|
Incidence | 2 | 2020 | 21308 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4672 | 0.060 |
Why?
|
Algorithms | 1 | 2024 | 13990 | 0.060 |
Why?
|
Chronic Disease | 1 | 2018 | 9304 | 0.050 |
Why?
|
Veterans Health | 1 | 2024 | 215 | 0.050 |
Why?
|
Aged | 3 | 2024 | 168773 | 0.050 |
Why?
|
Self Report | 2 | 2023 | 3717 | 0.050 |
Why?
|
Ritonavir | 1 | 2022 | 329 | 0.050 |
Why?
|
New York City | 1 | 2023 | 730 | 0.050 |
Why?
|
Hypertension | 1 | 2021 | 8527 | 0.050 |
Why?
|
History, 17th Century | 1 | 2020 | 107 | 0.040 |
Why?
|
Famous Persons | 1 | 2020 | 109 | 0.040 |
Why?
|
Child | 3 | 2022 | 80070 | 0.040 |
Why?
|
Researcher-Subject Relations | 1 | 2018 | 15 | 0.040 |
Why?
|
Prescriptions | 1 | 2021 | 386 | 0.040 |
Why?
|
Adolescent | 4 | 2022 | 88173 | 0.040 |
Why?
|
Food | 1 | 2023 | 771 | 0.040 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 26043 | 0.040 |
Why?
|
Publication Bias | 1 | 2018 | 160 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2020 | 64583 | 0.030 |
Why?
|
Analgesics, Opioid | 2 | 2022 | 3790 | 0.030 |
Why?
|
HIV | 1 | 2022 | 1582 | 0.030 |
Why?
|
Publications | 1 | 2018 | 194 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58838 | 0.030 |
Why?
|
Birth Weight | 1 | 2023 | 2097 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1749 | 0.030 |
Why?
|
Publishing | 1 | 2022 | 833 | 0.030 |
Why?
|
Life Expectancy | 1 | 2021 | 1236 | 0.030 |
Why?
|
Prevalence | 2 | 2021 | 15689 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10174 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2021 | 1333 | 0.030 |
Why?
|
SEER Program | 1 | 2018 | 1449 | 0.030 |
Why?
|
Medication Adherence | 1 | 2023 | 2166 | 0.020 |
Why?
|
Critical Illness | 1 | 2024 | 2722 | 0.020 |
Why?
|
Patient Preference | 1 | 2018 | 924 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2021 | 1416 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 3008 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3066 | 0.020 |
Why?
|
Neoplasms | 1 | 2018 | 22077 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15252 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 7995 | 0.020 |
Why?
|
Cause of Death | 1 | 2018 | 3682 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2020 | 4475 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10758 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10491 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8213 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 73999 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 80414 | 0.010 |
Why?
|